Berobenatide
A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)
Pfizer · Phase 3 · Recruiting · Enrollment 656
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| Placebo | n/r | n/r | n/r | n/r |
| Arm 1: Berobenatide Once Monthly | n/r | n/r | n/r | n/r |
| Arm 2: Berobenatide Once Monthly | n/r | n/r | n/r | n/r |
| Arm 3: Berobenatide Once Monthly | n/r | n/r | n/r | n/r |
Not shown
- Placebo: endpoint not reported
- Arm 1: Berobenatide Once Monthly: endpoint not reported
- Arm 2: Berobenatide Once Monthly: endpoint not reported
- Arm 3: Berobenatide Once Monthly: endpoint not reported